Knight Therapeutics files supplemental Brazil submission for Minjuvi
Knight Therapeutics announced a supplemental regulatory submission for Minjuvi in Brazil.
Story updates
10:07:25 PM UTC
SquawkNews
Knight Therapeutics Announces Supplemental Regulatory Submission for MINJUVI® (tafasitamab) in Brazil
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.